Thailand’s Largest Hospital to Initiates Ivermectin Clinical Trial in COVID-19 Patients

Thailand’s Largest Hospital to Initiates Ivermectin Clinical Trial in COVID-19 Patients.

The oldest and largest hospital in Thailand, Bangkok-based Siriraj Hospital with Mahidol University, makes a move to test Ivermectin in COVID-19 patients. Founded in 1888 by King Chulalongkorn after a cholera outbreak, the hospital today has 2,221 beds. The hospital is affiliated with autonomous research institution Mahidol University. 


Mahidol University’s Siriraj, Thailand’s largest hospital is the latest institution to embrace Ivermectin as a potential therapy for COVID-19.

The Study

Officially titled "Comparative of Ivermectin Versus Combination of Hydroxychloroquine plus Darunavir/Ritonavir for shortening the Duration of SARS-CoV-2 Detection from Respiratory Secretion Among Asymptomatic or Afebrile COVID-19 Infection," the study is planned to commence in July 2020 and run through November 2021.

The open label randomized controlled Phase IV study of oral ivermectin (600 mcg/kg/d* 3 day) versus combined of hydroxychloroquine plus darunavir/ritonavir for five days treatment among asymptomatic carrier of SARS-CoV-2 adult Thai population. Study outcomes under investigation include safety and duration of detectable of COVID-19 in nasopharyngeal/throat (NP)...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee